Close

ATARA Biotherapeutics (ATRA) to Present Data from Ongoing CMV-CTL Phase 2 in CMV-Specific CTL

Go back to ATARA Biotherapeutics (ATRA) to Present Data from Ongoing CMV-CTL Phase 2 in CMV-Specific CTL